By Editor , 2 October 2026
FDA Approves Lilly's Jaypirca as First-Line CLL/SLL Therapy

Indianapolis – October 02, 2026 -- The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly and Company's Jaypirca (pirtobrutinib), clearing the non-covalent BTK inhibitor as a first-line treatment for adult patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) without 17p deletion.

By Editor , 2 October 2026
California Discloses $40.1B in UC, Community College Payroll Data

Sacramento – October 02, 2026 -- California State Controller Malia M. Cohen released 2025 self-reported payroll data for University of California (UC) campuses and California Community College Districts (CCD), covering 451,244 positions, more than $34 billion in wages and over $6 billion in retirement and health contributions, for total compensation exceeding $40.1 billion.

By Editor , 2 October 2026
Newsom Signs SCAG-Backed SB 1087, Builders Call It a 'Housing Killer'

Irvine, Calif. – October 02, 2026 -- Governor Gavin Newsom signed Senate Bill 1087 on September 30, legislation sponsored by the Southern California Association of Governments (SCAG) that the Building Industry Association of Southern California (BIASC) says will raise housing costs and erode local planning authority across the region.

By Editor , 2 October 2026
Rigel Pharmaceuticals Grants 35,275 RSUs to 18 New Hires

South San Francisco, Calif. – October 02, 2026 -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has granted 35,275 restricted stock units to 18 non-executive employees under its Inducement Plan.

Rigel ties new hire equity to four-year vesting schedule

The restricted stock units vest over four years, with 25% of each grant releasing annually. The Compensation Committee of Rigel's Board of Directors approved the awards as an inducement material to new employees joining the company.

By Editor , 2 October 2026

Tianjin, China – October 02, 2026 -- Tianjin University's "Shengong-Shengao" system has become China's first approved brain-computer interface (BCI) medical device for diagnosing cognitive impairment, cutting diagnosis time for conditions like hydrocephalus from days to just 30 minutes. The milestone marks a commercial breakthrough as TJU, China's first modern university, marks its 131st anniversary on October 2, 2026.

By Editor , 2 October 2026
DOOR Ends Four-Year SEC Probe With $1 Million Settlement

St. Louis – October 01, 2026 -- DOOR (OTC: LTCH) has finalized a settlement with the U.S. Securities and Exchange Commission, closing a four-year investigation into legacy revenue recognition and key performance indicator practices with a $1.0 million civil penalty payable in quarterly installments.

SEC closes investigation that began in 2022

The SEC approved the previously disclosed settlement, which the Company first announced in principle on August 10, 2026. DOOR consented to an administrative order without admitting or denying the regulator's findings.

By Editor , 2 October 2026
Curaleaf's QMID Becomes First TGA-Registered Cannabis Inhaler in Australia

London – October 01, 2026 -- Curaleaf International's Que Medical Inhalation Device (QMID) has become the first cannabis inhalation device to secure registration from Australia's Therapeutic Goods Administration, clearing the way for clinicians to prescribe a standardized-dosing device in a market that has treated more than one million patients since 2016.

By Editor , 2 October 2026
SerpApi Earns ISO/IEC 27701 Privacy Certification

Austin, Texas – October 01, 2026 -- SerpApi, a provider of structured search data APIs, has achieved ISO/IEC 27701:2019 certification, an internationally recognized standard for Privacy Information Management Systems (PIMS).

By Editor , 2 October 2026
ANSI, America Makes Launch AM Standards Database, Gaps Report

New York – October 01, 2026 -- The American National Standards Institute (ANSI) and America Makes have launched a searchable online database of additive manufacturing (AM) standards alongside a September 2026 Gaps Progress Report, giving manufacturers and regulators a clearer map of which safety and performance standards exist, which are in development, and where coverage is still missing.